Amanta Healthcare Limited (NSE:AMANTA)

Market Cap	4.42B
Revenue (ttm)	2.83B -2.0%
Net Income	136.68M
EPS	4.17
Shares Out	34.34M
PE Ratio	30.89
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,147,362
Average Volume	184,484
Open	123.50
Previous Close	121.03
Day's Range	119.00 - 131.70
52-Week Range	92.00 - 154.40
Beta	n/a
RSI	79.95
Earnings Date	Jul 31, 2026

About Amanta Healthcare

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory ca...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 522
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AMANTA

Financial Performance

In fiscal year 2025, Amanta Healthcare's revenue was 2.75 billion, a decrease of -2.01% compared to the previous year's 2.80 billion. Earnings were 105.01 million, an increase of 189.02%.